+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
United Kingdom Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices- Product Image
United Kingdom Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices- Product Image
New

United Kingdom Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices

  • PDF Icon

    Report

  • 45 Pages
  • February 2026
  • Region: United Kingdom
  • GlobalData
  • ID: 6058735
Description Jump to:

The United Kingdom Neuromodulation Devices Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2025 company share data for Neuromodulation Devices Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Report Scope

United Kingdom Neuromodulation Devices is segmented as follows:

  • Implantable Neuromodulation Devices
  • Minimally Invasive Neuromodulation Devices
  • Non-Invasive Neuromodulation Devices

Reasons to Buy

The United Kingdom Neuromodulation Devices Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, United Kingdom
3.1 Neuromodulation Devices Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Implantable Neuromodulation Devices Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Implantable Neuromodulation Devices Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Neuromodulation Devices Market, United Kingdom, Average Price ($), 2018-2033
3.4 Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in United Kingdom, Neuromodulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 LivaNova Plc
4.4.1 Company Overview
4.5 Enterra Medical Inc
4.5.1 Company Overview
4.6 Nevro Corp
4.6.1 Company Overview
4.7 Axonics Inc
4.7.1 Company Overview
4.8 B. Braun Melsungen AG
4.8.1 Company Overview
4.9 Bioness Inc
4.9.1 Company Overview
4.10 Xavant Technology (Pty) Ltd
4.10.1 Company Overview
5 Neuromodulation Devices Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Nov 03, 2025: Neurovalens Secures £6m Funding
6.1.2 Oct 16, 2025: IXICO CEO Bram Goorden Discusses Strong 2025 Performance And 2026 Priorities
6.1.3 Oct 06, 2025: GSK Appoints Luke Miels As CEO Designate
6.1.4 Jun 24, 2025: GSK Announces Director Declaration
6.1.5 Jun 09, 2025: Nottinghamshire Healthcare receives funding for infrastructure improvements
6.2 Financial Announcements
6.2.1 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
6.3 Government and Public Interest
6.3.1 Aug 22, 2025: LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
6.4 Other Significant Developments
6.4.1 Oct 16, 2025: IXICO CEO Bram Goorden Discusses Strong 2025 Performance And 2026 Priorities
6.5 Product News
6.5.1 Nov 21, 2025: Brainbox and Sonic Concepts Deliver 100 NeuroFUS Systems Worldwide
6.5.2 Nov 03, 2025: Neurovalens Secures £6m Funding
6.5.3 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
6.5.4 Oct 31, 2025: New Project Aims to Transform Implantable Medical Devices
6.5.5 Oct 20, 2025: Neupulse Attends Launch of N3 Centre for Neurotechnology
6.5.6 Sep 10, 2025: Neurocare Group's Apollo TMS Therapy Devices Granted FDA Clearance for Treating Adolescent Depression
6.5.7 Sep 08, 2025: Onward Medical Receives CE Mark for Arc-Ex, Enabling Commercial Launch in Europe
6.6 Strategy And Business Planning
6.6.1 Nov 21, 2025: Brainbox and Sonic Concepts Deliver 100 NeuroFUS Systems Worldwide
6.6.2 Nov 13, 2025: Partnership Enhances Patient Access to Neurotechnologies
6.6.3 Nov 03, 2025: Neurovalens Secures £6m Funding
6.6.4 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
6.6.5 Oct 20, 2025: Neupulse Attends Launch of N3 Centre for Neurotechnology
6.6.6 Oct 16, 2025: IXICO CEO Bram Goorden Discusses Strong 2025 Performance And 2026 Priorities
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Implantable Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
Table 4: Implantable Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
Table 5: Neuromodulation Devices Market, United Kingdom, Average Price ($), 2018-2033
Table 6: Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2025
Table 7: Neuromodulation Devices Market Pipeline Products
Table 8: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Implantable Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
Figure 4: Implantable Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
Figure 5: Neuromodulation Devices Market, United Kingdom, Company Share (%), 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • LivaNova Plc
  • Enterra Medical Inc
  • Nevro Corp
  • Axonics Inc
  • B. Braun Melsungen AG
  • Bioness Inc
  • Xavant Technology (Pty) Ltd

Related Topics

Related Reports

Neuromodulation Devices Market Size, Share & Trends Analysis Report by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators), Application (Migraine, Epilepsy, Chronic Pain, Depression), End-use, and Region with Growth Forecasts, 2026-2033 - Product Image

Neuromodulation Devices Market Size, Share & Trends Analysis Report by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators), Application (Migraine, Epilepsy, Chronic Pain, Depression), End-use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033 - Product Image

Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
EU5 Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others - Product Image

EU5 Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

  • Report
  • 209 Pages
  • Europe
From
Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • 53 Pages
  • Global
From
Internal Neuromodulation Devices Market Report 2026 - Product Image

Internal Neuromodulation Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Neuromodulation Device Market

Neuromodulation devices are medical devices used to treat neurological disorders and chronic pain. These devices are used in a variety of surgical procedures, such as deep brain stimulation, spinal cord stimulation, and sacral nerve stimulation. Neuromodulation devices are designed to deliver electrical stimulation to the nervous system, which can help reduce pain, improve movement, and restore normal functioning. Neuromodulation devices are used in a variety of surgical procedures, including neurosurgery, orthopedic surgery, and plastic surgery. In neurosurgery, neuromodulation devices are used to treat conditions such as Parkinson's disease, epilepsy, and chronic pain. In orthopedic surgery, neuromodulation devices are used to treat conditions such as spinal cord injuries, chronic pain, and muscle spasms. In plastic surgery, neuromodulation devices are used to treat conditions such as facial paralysis and facial nerve damage. Some of the companies in the neuromodulation device market include Medtronic, Boston Scientific, St. Jude Medical, Abbott, and Cyberonics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.